)
)
Ambrx Biopharma Investor Relations Material
Latest events
Investor Day 2023
Ambrx Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ambrx Biopharma Inc
Access all reports
Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of antibody drug conjugates (ADCs) and other engineered therapies aimed at modulating the immune system. The company is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
AMAM
Country
🇺🇸 United States